RFA #: 1212030210
Institution |
PI | Amount | Title |
---|---|---|---|
Icahn School of Medicine at Mount Sinai | Ronald Hoffmann | $8,782,529 | Commercialization of Valproic Acid Expanded Cord Blood Stem Cells as Allogeneic Grafts for Adults with Refractory Hematological Malignancies |
Roswell Park Cancer Institute | Kunle Odunsi | $11,922,885 | Programing Hematopoetic Stem Cells for Long-Term Targeted T Cell Therapy of Patients with Relapsed Ovarian Cancer |
Weill Cornell Medical College | Shahin Rafii | $15,717,575 | Vascular Niche Platform to Expand Hematopoietic Stem and Progenitor Cells Engineered to Cure Sickle Cell Disease |
Please visit the Developing Cures page for more information.